TERN Insider Trading Activity and SEC Form 4 Filings
TERN insider trading summary
Over the past 12 months, insiders at Terns Pharmaceuticals, Inc. (TERN) reported 11 sales worth $6.6M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $6.6M.
Latest TERN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2026 | Emil Kuriakose | Chief Medical Officer | Sell | $50K (942 @ $52.75) |
| Mar 16, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $131K (2,770 @ $47.30) |
| Mar 16, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $550K (11,813 @ $46.57) |
| Feb 17, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $163K (4,083 @ $39.80) |
| Feb 17, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $89K (2,341 @ $38.07) |
| Feb 17, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $320K (8,159 @ $39.22) |
| Jan 15, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $282K (7,521 @ $37.53) |
| Jan 15, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $2.3M (61,228 @ $37.02) |
| Jan 5, 2026 | Amy L. Burroughs | Chief Executive Officer | Sell | $2.7M (71,339 @ $38.10) |
| Jan 2, 2026 | Emil Kuriakose | Chief Medical Officer | Sell | $8K (200 @ $39.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.